Minnow Street Minnow Street
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Thermo Fisher Scientific Inc (TMO)

Healthcare Diagnostics & Research
574.30 $
-0.4% vs. previous close
Closing price · As of: 31. Jul 2026

Thermo Fisher Scientific Inc (TMO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 113,174 million $. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly
Balance Sheet TMO
Tick rows to compare them in a chart (up to 4) Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
97,057 98,726 97,095 98,496 100,364 97,321 99,041 101,230 103,020 110,343 113,281 113,174
23,092 24,589 23,640 25,476 23,783 22,137 23,378 24,584 22,295 28,707 22,316 23,365
6,151 8,077 5,506 7,084 4,645 4,019 4,134 4,579 1,982 9,857 3,254 4,064
6,151 8,077 7,257 8,834 6,645 5,580 5,947 6,393 3,546 10,110 3,256 4,064
9,835 9,664 9,353 9,430 9,796 9,626 9,821 10,035 10,531 10,566 10,888 9,451
5,404 5,088 5,133 5,198 5,430 4,978 5,224 5,559 5,745 5,425 5,496 5,627
9,167 – – – 9,412 9,306 9,331 9,635 10,177 10,565 – –
43,583 44,020 43,843 43,843 46,726 45,853 46,493 47,249 49,287 49,362 55,187 54,832
17,091 16,670 16,048 15,519 16,262 15,533 15,323 15,148 16,242 15,838 19,146 18,606
51,593 51,884 51,472 50,963 51,265 47,650 49,555 50,628 51,996 56,807 61,341 60,488
14,158 14,012 13,937 14,772 14,601 13,332 13,174 12,718 14,888 15,189 14,621 15,069
4,795 3,872 4,451 5,121 4,116 2,475 2,819 2,214 3,823 3,808 3,090 3,368
2,508 2,872 2,555 2,547 2,606 3,079 3,049 2,980 2,980 3,622 3,344 –
30,489 31,308 31,157 30,284 31,197 29,061 31,370 33,015 31,857 35,852 40,071 –
45,328 46,735 45,516 47,432 48,992 49,584 49,390 50,511 51,024 53,407 51,940 52,686
45,869 47,364 48,542 49,940 51,421 53,102 54,447 55,901 55,901 59,156 60,632 62,194
388 388 384 383 384 383 379 378 378 377 373 371

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?